Breaking News
February 16, 2019 - Conformance of genetic characteristics found to be crucial for longer preservation of kidney graft
February 16, 2019 - Researchers use optogenetic tool to control, visualize receptor signals in neural cells
February 16, 2019 - New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis
February 16, 2019 - Testosterone is not the only hormone needed for penis development
February 16, 2019 - FDA Advisory Committee Recommends Approval of Spravato (esketamine) Nasal Spray for Adults with Treatment-Resistant Depression
February 15, 2019 - Heart surgery technology developed at Baptist Health debuts after years of secrecy
February 15, 2019 - Prescription Opioids Double Risk of Triggering Fatal Car Crash
February 15, 2019 - New study helps doctors better understand high blood pressure in pregnant women
February 15, 2019 - Beta wave control in Parkinson’s diseased brain could be a potential therapy
February 15, 2019 - Media representations of love may justify gender-based violence in young people
February 15, 2019 - Yoga May Help With Rheumatoid Arthritis Symptoms, Severity
February 15, 2019 - Obstructive sleep apnea linked to inflammation, organ dysfunction
February 15, 2019 - Master your mind: A challenge from WELL for Life
February 15, 2019 - Why Some Brain Tumors Respond to Immunotherapy
February 15, 2019 - Must-Reads Of The Week From Brianna Labuskes
February 15, 2019 - Researchers uncover novel mechanism and potential new therapeutic target for Alzheimer’s
February 15, 2019 - Genetic variations in a fourth gene associated with higher ALL risk in Hispanic children
February 15, 2019 - Disruptive behavioral problems in kindergarten linked with lower employment earnings in adulthood
February 15, 2019 - New bioengineered device enhances the production of T-cells
February 15, 2019 - HDL proteome behaves like a tiny Velcro ball that is rolling on surfaces
February 15, 2019 - Puerto Rican children more likely to have poor or decreasing use of asthma inhalers
February 15, 2019 - Quality of patient care does not improve after physician-hospital integration
February 15, 2019 - Synopsys release new software for implant design and patient-specific planning
February 15, 2019 - 6 out of 10 hip replacements last 25 years or longer
February 15, 2019 - Health Tip: What You Should Know About Antibiotics
February 15, 2019 - New research challenges medical consensus that adenoids and tonsils significantly shrink during teenage years
February 15, 2019 - Discovery of weakness in a rare cancer could be exploited with drugs
February 15, 2019 - UVA scientists find potential explanation for mysterious cell death in Alzheimer’s, Parkinson’s
February 15, 2019 - New rules requiring female athletes to lower testosterone levels are based on flawed data
February 15, 2019 - Researchers comprehensively sequence the human immune system
February 15, 2019 - Researchers study animal venoms to identify new medicines for treating diseases
February 15, 2019 - Movement of wrist bones revealed by MRI and computer modeling
February 15, 2019 - Philips introduces new premium digital X-ray room to help shorten patient wait times
February 15, 2019 - Women fare worse than men following aortic heart surgery, study finds
February 15, 2019 - High-protein and low-calorie diet helps older adults lose weight safely, shows study
February 15, 2019 - Drug microdosing effects may not measure up to big expectations
February 15, 2019 - Discharged, Dismissed: ERs Often Miss Chance To Set Overdose Survivors On ‘Better Path’
February 15, 2019 - A digitized lab environment to be showcased at smartLAB 2019
February 15, 2019 - Scientists uncover main mechanisms of fluconazole drug resistance
February 15, 2019 - New study seeks to understand how colibactin causes cancer
February 15, 2019 - Photoacoustic imaging accurately measures the temperature of deep tissues
February 15, 2019 - Large study finds no association between phthalate exposure and breast cancer risk
February 15, 2019 - New research explains presence of ‘natural’ magnetism in human cells
February 15, 2019 - Bio-Rad launches new digital PCR system and kit for monitoring treatment response in CML patients
February 15, 2019 - Scientists shed light on damaging cell effects linked to aging
February 15, 2019 - Celiac disease may be caused by stomach bug in childhood
February 15, 2019 - NHS performance figures highlight the true scale of Emergency Department crisis
February 15, 2019 - High intensity exercise may improve health by increasing gut microbiota diversity
February 15, 2019 - Apellis’ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of Autoimmune Hemolytic Anemia
February 15, 2019 - Couples creating art or playing board games release ‘love hormone’
February 15, 2019 - Glimpsing The Future At Gargantuan Health Tech Showcase
February 15, 2019 - Common herbicide found to increase the risk of lymphoma
February 15, 2019 - Over-abundance of energy to cells could increase cancer risk
February 15, 2019 - Oxford Genetics appoints Jocelyne Bath as new Chief Operating Officer
February 15, 2019 - Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors
February 15, 2019 - Large-scale clinical trial begins to study liver transplantation between people with HIV
February 15, 2019 - Cannabis use among adolescents linked with increased risk of depression in adulthood
February 15, 2019 - Fractures, head injuries common in electric scooter accidents, UCLA study finds
February 15, 2019 - Prenatal maternal depression has important consequences for infant temperament, study shows
February 15, 2019 - Stereotactic body radiotherapy effective in treating men with low- or intermediate-risk prostate cancer
February 15, 2019 - Zogenix Submits New Drug Application to U.S. Food & Drug Administration for Fintepla for the Treatment of Dravet Syndrome
February 15, 2019 - Certain birthmarks warrant quick treatment, pediatricians say
February 15, 2019 - New machine learning method predicts if atypical ductal hyperplasia will turn cancerous
February 15, 2019 - Whole-genome sequencing and sharing real-time data could limit spread of foodborne bacteria
February 15, 2019 - FDA warns doctor for illegally marketing unapproved implantable device
February 15, 2019 - New injury documentation tool may provide better evidence for elder abuse cases
February 15, 2019 - Physiological age is a better predictor of survival than chronological age, shows study
February 15, 2019 - New study reveals high success rate for hip and knee replacements
February 15, 2019 - Prenatal exposures to BPA may pose threat to human ovarian function
February 15, 2019 - Suspicious spots on the lungs of children with rhabdomyosarcoma do not behave like metastases
February 15, 2019 - Diet drinks daily could raise stroke risk says study
February 15, 2019 - Many Systematic Reviews Do Not Fully Report Adverse Events
February 15, 2019 - Seven tips to protect your child from burns
February 15, 2019 - Keynote speakers announced for CBD Expo MIDWEST
February 15, 2019 - New DNA methylation GrimAge tool allows you to predict lifespan and healthspan
February 15, 2019 - New AI-driven platform analyze how pathogens infect human cells
February 15, 2019 - Increased activity of EHMT2 gene deficient neurons could cause autism in humans
February 15, 2019 - Recurring UTIs may mask symptoms of bladder or kidney cancer
February 15, 2019 - Researchers conduct extensive comparison of drugs used in treating neuroendocrine tumors
February 15, 2019 - Depression prevention for pregnant women and new mothers – new recommendations
Cell-Free DNA May Help Pinpoint Breast Ca Survival

Cell-Free DNA May Help Pinpoint Breast Ca Survival

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study suggests that a high tumor fraction of cell-free DNA is prognostic of worse survival in patients with metastatic triple-negative breast cancer.
  • Be aware that this disease carries a poor prognosis overall, making further risk stratification an important step towards targeting potentially toxic therapies.

The tumor fraction of cell-free DNA (cfDNA) sample can be used to predict survival in patients with metastatic triple-negative breast cancer (TNBC), investigators reported.

This suggests that determining cfDNA tumor fraction via a minimally invasive blood test can provide “important prognostic information beyond standard clinicopathologic factors,” according to Daniel G. Stover, MD, of the Ohio State University Comprehensive Cancer Center in Columbus, and colleagues.

A diagnosis of TNBC means that the breast cancer cells have tested negative for hormone epidermal growth factor receptor 2 (HER-2), and estrogen and progesterone receptors. TNBC accounts for 10% to 15% of breast cancers, yet is responsible for more than one-third of breast cancer deaths, the authors wrote in the Journal of Clinical Oncology.

They also noted that TNBC is characterized by relatively few mutations, but widespread somatic copy number alterations (SCNAs), suggesting SCNAs play a critical from in the formation of TNBC tumors. Stover’s group evaluated SCNAs in metastatic TNBC via cfDNA to determine whether cfDNA tumor fraction was associated with overall metastatic TNBC survival.

For this retrospective cohort study, they identified 506 plasma samples from 164 patients with biopsy-proven metastatic TNBC. All patients received chemotherapy before blood collection, with most patients receiving neoadjuvant or adjuvant anthracycline and taxane-based chemotherapy.

The researchers used an algorithm, ichorCNA, to profile SCNAs and quantify tumor fraction (TFx) in cfDNA from low-coverage whole-genome sequencing without prior knowledge of the genomic changes in the patient’s tumor.

Stover’s group was able to determine tumor fraction of cfDNA for 158 patients (96.3%). Also, 101 of those 158 patients (63.9%) had at least one sample with TFx equal to or greater than the prespecified cfDNA tumor fraction threshold of 10%.

Crucially, they found that patients with the higher tumor fraction of ≥10% was associated with a “significantly shorter survival” — median 6.4 months versus 15.9 months — and that this association remained significant independent of clinicopathologic factors (hazard ratio 2.14, 95% CI 1.4-3.8).

The analysis also identified several genes — NOTCH2, AKT2, and AKT3 — that had copy number gains enriched in metastatic TNBCs relative to primary TNBCs. In an accompanying commentary, Sarah-Jane Dawson, MD, PhD, of the Peter MacCallum Cancer Center in Melbourne, Australia, and colleague observed that this “sheds light on important genes and signaling pathways that may be perturbed in metastatic disease.”

Stover’s group also found that more than half of metastatic TNBCs harbored gains or amplification of 18q11, 19p13, or both, which was significantly more frequent than in primary TNBCs. “Gain or amplification of both regions identifies a subset of TNBC rapid progressors with remarkably poor survival in the metastatic, and also the primary setting,” they wrote.

The study illustrates a “framework for minimally invasive genomic characterization of metastatic cancer and subsequent integration with clinicopathologic data and patient outcomes,” the authors noted. “This approach has the potential to reveal clinically useful biomarkers while identifying unique genomic features of metastatic cancer and may advance our understanding of metastasis, drug resistance, and novel therapeutic targets.”

Dawson’s group wrote that with “the current lack of prognostic markers in metastatic TNBC, a reliable marker that can be obtained using a minimally invasive blood draw could have important implications.”

They also pointed out that it was important to note that the SCNA analysis was only performed on those patients (63.9% of the cohort) whose TFx was ≥10%. “High-confidence copy number calls could not be achieved for samples with a TFx < 10%, " they wrote, adding this would "limit the applicability of this approach in patients with early-stage disease."

But considering the challenges posed by the heterogeneity of TNBC, and the lack of targeted therapeutic options in treating the disease, the “era of comprehensive molecular characterization promises to pave the way forward,” Dawson’s group wrote.

The study was supported by the Gerstner Family Foundation, Susan G. Komen for the Cure, The Pink Agenda, Breast Cancer Research Foundation, the V Foundation for Cancer Research, and Dana-Farber/Harvard Cancer Center National Cancer Institute Specialized Programs of Research Excellence in Breast Cancer.

Stover disclosed no relevant relationships with industry. Co-authors disclosed multiple relevant relationships with industry.

Dawson and co-author disclosed support from Cancer Therapeutics CRC, the National Breast Cancer Foundation, the Victorian Cancer Agency, and the National Health and Medical Research Council of Australia.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-12-01T00:00:00-0500

last updated

Tagged with:

About author

Related Articles